An oral version of the GLP-1 drug semaglutide failed to significantly slow the disease's progression compared to a placebo.

Chris Hemsworth's touching road trip with his father Craig, who has "early-stage Alzheimer's," is chronicled in a National ...

We break down the current state of frontotemporal dementia, from bvFTD to PPA, and why 'promising' therapies are still far ...

Alzheimer's disease affects about 250,000 older adults in Illinois. Experts and those who have had to take care of loved ones ...

Rutgers neuroscientist Peng Jiang and his neuroscience colleague Mengmeng Jin have made a discovery they say could reshape ...

An oral version of semaglutide, the active ingredient in blockbuster drugs Ozempic and Wegovy, failed to slow the progression ...

Top-line results from two large clinical trials by Novo Nordisk, the company behind Ozempic and Wegovy, found oral ...

In this interview, Kalpana Barnes highlights how new approach methodologies are addressing the gaps in drug discovery studies ...

Growing up, Dina Xu Callaway had fond memories of her live-in grandparents, who helped raise her and her sister. Inspired by ...

In people at risk for Alzheimer’s disease, researchers linked minimal to moderate physical activity to a 3-to 7-year delay in cognitive symptoms.

Researchers have discovered a natural mechanism that clears existing amyloid plaques in the brain and preserves cognitive ...

Scientists discovered that lowering a specific molecule helps microglia switch into a protective state that quiets brain ...